We've got the first data suggesting a next generation Covid vaccine could outperform the Pfizer vax – it's authorized in one country & manufacture is ramping up.
The number of nextgen vaxes reaching mid-stage trials (phase 2) is now in double digits.
We've been hearing results of 2 clinical trials a month for the last 6 months.